{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:08:30Z","timestamp":1790050110930,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.actatropica.2007.05.005","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T16:21:04Z","timestamp":1179591664000},"page":"33-40","source":"Crossref","is-referenced-by-count":107,"title":["Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran"],"prefix":"10.1016","volume":"103","author":[{"given":"M.","family":"Mohebali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hooshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Akhoundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rahnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Razaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2007.05.005_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate vs. cryotherapy and interalesional meglumine antimoniate alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int. J. Dermatol."},{"issue":"8","key":"10.1016\/j.actatropica.2007.05.005_bib2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","article-title":"Miltefosine to treatment leishmaniasis: drug evaluation","volume":"6","author":"Berman","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.actatropica.2007.05.005_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0037-86821995000200002","article-title":"Evaluation of a direct immunofluorescent antibody (DIFMA) test using Leishmania genus \u2013 specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis","volume":"28","author":"Chico","year":"1995","journal-title":"Rev. Soc. Dras. Med. Trop."},{"key":"10.1016\/j.actatropica.2007.05.005_bib4","unstructured":"Diseases Management Center, Ministry of Health, Treatment and Medical Education of Iran; 2002\u20132003. Annual Communicable Diseases Report."},{"key":"10.1016\/j.actatropica.2007.05.005_bib5","first-page":"22","article-title":"Visceral leishmaniasis: the Iranian experiences","volume":"1","author":"Edrissian","year":"1999","journal-title":"Arch. Iranian Med. J."},{"issue":"5","key":"10.1016\/j.actatropica.2007.05.005_bib6","doi-asserted-by":"crossref","first-page":"e 162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian Cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLOS. Med."},{"key":"10.1016\/j.actatropica.2007.05.005_bib7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2007.05.005_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2007.05.005_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of anti-proliferative lysophospholipid analogues against protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor Ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2007.05.005_bib10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.26719\/2001.7.6.912","article-title":"Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran","volume":"7","author":"Mohebali","year":"2001","journal-title":"East. Mediterr. Health J."},{"key":"10.1016\/j.actatropica.2007.05.005_bib11","first-page":"243","article-title":"Identification of Leishmania species from different parts of Iran using a random amplified polymorphic DNA in human animal reservoirs and vectors","volume":"15","author":"Mohebali","year":"2002","journal-title":"Med. J. Islamic Rep. Iran"},{"key":"10.1016\/j.actatropica.2007.05.005_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.26719\/2004.10.4-5.591","article-title":"Study on Leishmania infection in caught rodents in some parts of I.R. of Iran","volume":"10","author":"Mohebali","year":"2004","journal-title":"East. Mediterr. Health J."},{"key":"10.1016\/j.actatropica.2007.05.005_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vetpar.2005.01.010","article-title":"Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran","volume":"129","author":"Mohebali","year":"2005","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.actatropica.2007.05.005_bib14","first-page":"40","article-title":"Treatment of non-healing cases of cutaneous leishmaniasis. Successful treatment using a combination of meglumine antimoniate plus allopurinol","volume":"13","author":"Momeni","year":"2003","journal-title":"E.J.D."},{"key":"10.1016\/j.actatropica.2007.05.005_bib15","first-page":"99","article-title":"A brief review of the epidemiology of various types of leishmaniasis in Iran","volume":"XIV","author":"Nadim","year":"1971","journal-title":"Acta Med. Iranica"},{"key":"10.1016\/j.actatropica.2007.05.005_bib16","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100S","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2007.05.005_bib17","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.actatropica.2007.05.005_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2007.05.005_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2007.05.005_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/14787210.4.2.177","article-title":"Miltefosine: oral treatment of leishmaniasis","volume":"4","author":"Soto","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.actatropica.2007.05.005_bib21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2007.05.005_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034989958096","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"Sundar","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2007.05.005_bib23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2007.05.005_bib24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2007.05.005_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","article-title":"Drug policy for visceral leishmaniasis: Cost-effectiveness analysis","volume":"12","author":"Vanlerberghe","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2007.05.005_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0001-706X(01)00085-7","article-title":"Epidemiological study in a new focus of cutaneous leishmaniasis due to Leishmania major in Ardestan town, central Iran","volume":"79","author":"Yaghoobi-Ershadi","year":"2001","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2007.05.005_bib27","first-page":"98","article-title":"A new focus of cutaneous leishmaniasis caused by Leishmania tropica","volume":"24","author":"Yaghoobi","year":"2002","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.actatropica.2007.05.005_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-6851(02)00220-7","article-title":"Choline transport in Leishmania major promastigotes and its inhibition by choline and phosphocholine analogs","volume":"125","author":"Zuffery","year":"2005","journal-title":"Mol. Biochem. Parasitol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X07001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X07001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:47:47Z","timestamp":1683830867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X07001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0001706X07001258"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2007.05.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1087557.540619","asserted-by":"object"}]},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}